Strategies for Reducing the Homogenization Phenomenon in the Screening of Key Components in Network Pharmacology Based on the Detectability of Components
Rapid Communications in Mass Spectrometry · 30.06.2025 · 39 (12)
DOI: 10.1002/rcm.10028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 25.03.2025. Verfasst von Kaiye Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Research and Development Center, Guangdong Pharmaceutical University, Guangzhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Network Pharmacology, Mass Spectrometry. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Background
The ingredients of traditional Chinese medicine (TCM) are complex and diverse and are often identified using the TCM systems pharmacology (TCMSP) database. However, the ingredients in this database exhibit significant homogeneity, which limits the comprehensive understanding of TCM's ingredient diversity and biological activity. Consequently, liquid chromatography–mass spectrometry (LC–MS) has become a key tool for the precise identification of TCM components.
Methods
In this study, the LC–MS was used to identify the components of a TCM herb. The identified components were then compared with the component data in the TCMSP database. A network pharmacological prediction of the components was subsequently performed.
Results
An analysis of the four herb formula prescriptions (Ganmai Dazao decoction, Bazhen granule, Shaoyao Gancao decoction, and Zixue san) was conducted, revealing significant discrepancies between the LC–MS identification results and the components in the TCMSP database. The database components were found to be highly homogeneous.
Conclusion
This study underscores the pivotal function of LC–MS in the analysis of components of TCM, particularly in addressing issues of database homogeneity. The employment of LC–MS technology enhances the precision of ingredient identification and streamlines the identification of potential pharmacodynamic ingredients, thereby propelling TCM toward a more contemporary standing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Drug Research and Development Center, Guangdong Pharmaceutical University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Guangdong Pharmaceutical University, Guangzhou, China.
- The Affiliated Yixing Hospital of Jiangsu University, Yixing, China.
- National Medical Products Administration Institute of Executive Development, Beijing, China.
ORCID-Profile: Mingxin Guo
Zitieren
APA
Peng, K., Xu, S., Li, M., Li, W., Zou, Y., Guo, M., & Wu, X. (2025). Strategies for Reducing the Homogenization Phenomenon in the Screening of Key Components in Network Pharmacology Based on the Detectability of Components. Rapid Communications in Mass Spectrometry, 39(12). https://doi.org/10.1002/rcm.10028
Vancouver
Peng K, Xu S, Li M, Li W, Zou Y, Guo M, et al. Strategies for Reducing the Homogenization Phenomenon in the Screening of Key Components in Network Pharmacology Based on the Detectability of Components. Rapid Communications in Mass Spectrometry. 2025;39(12). doi:10.1002/rcm.10028
BibTeX
@article{Peng2025,
author = {Peng, Kaiye and Xu, Sang and Li, Minpeng and Li, Wei and Zou, Yun and Guo, Mingxin and Wu, Xia},
title = {Strategies for Reducing the Homogenization Phenomenon in the Screening of Key Components in Network Pharmacology Based on the Detectability of Components},
journal = {Rapid Communications in Mass Spectrometry},
year = {2025},
volume = {39},
number = {12},
doi = {10.1002/rcm.10028}
}
EUVIMED